A letter to the editor is presented in response to the article "Factors associated with ordering laboratory monitoring of high-risk medications" by Shira H. Fischer, Jennifer Tjia, George Reed, Daniel Peterson, Jerry H Gurwitz and Terry S. Field published in the same issue.